On Monday, Windtree Therapeutics Inc (NASDAQ: WINT) opened higher 18.92% from the last session, before settling in for the closing price of $1.48. Price fluctuations for WINT have ranged from $1.45 to $737.43 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -25.00%. Company’s average yearly earnings per share was noted 96.33% at the time writing. With a float of $0.75 million, this company’s outstanding shares have now reached $0.75 million.
Let’s determine the extent of company efficiency that accounts for 15 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Windtree Therapeutics Inc (WINT) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Windtree Therapeutics Inc is 0.13%, while institutional ownership is 0.84%. The most recent insider transaction that took place on Oct 08 ’24, was worth 4,942. In this transaction President and CEO of this company bought 5,431 shares at a rate of $0.91, taking the stock ownership to the 8,638 shares.
Windtree Therapeutics Inc (WINT) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 96.33% per share during the next fiscal year.
Windtree Therapeutics Inc (NASDAQ: WINT) Trading Performance Indicators
Check out the current performance indicators for Windtree Therapeutics Inc (WINT). In the past quarter, the stock posted a quick ratio of 0.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -931.66, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -314.75 in one year’s time.
Technical Analysis of Windtree Therapeutics Inc (WINT)
Looking closely at Windtree Therapeutics Inc (NASDAQ: WINT), its last 5-days average volume was 29.99 million, which is a jump from its year-to-date volume of 3.1 million. As of the previous 9 days, the stock’s Stochastic %D was 15.62%. Additionally, its Average True Range was 0.71.
During the past 100 days, Windtree Therapeutics Inc’s (WINT) raw stochastic average was set at 0.70%, which indicates a significant decrease from 15.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 237.76% in the past 14 days, which was higher than the 138.47% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.6990, while its 200-day Moving Average is $122.1971. However, in the short run, Windtree Therapeutics Inc’s stock first resistance to watch stands at $2.0700. Second resistance stands at $2.3800. The third major resistance level sits at $2.5900. If the price goes on to break the first support level at $1.5500, it is likely to go to the next support level at $1.3400. Should the price break the second support level, the third support level stands at $1.0300.
Windtree Therapeutics Inc (NASDAQ: WINT) Key Stats
There are currently 749K shares outstanding in the company with a market cap of 1.23 million. Presently, the company’s annual sales total 0 K according to its annual income of -20,290 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -2,750 K.
